Prof. MD. Duygu Derin

Education

1987 — Galatasaray Lycée, Istanbul 1993 — Istanbul University, Istanbul Faculty of Medicine, Doctor of Medicine 2001 — Specialty Training in Internal Medicine, Taksim Training and Research Hospital 2003 – 2006 — Subspecialty Training in Medical Oncology, Istanbul University, Istanbul Faculty of Medicine, Institute of Oncology 2010 — Associate Professorship in Medical Oncology

Professional Experience

2006 – 2008 — Kayseri Training and Research Hospital, Department of Medical Oncology (Compulsory Service) 2009 – 2010 — American Hospital, Istanbul (Medical Oncologist) 2010 – 2016 — Neolife Oncology Centre (Medical Oncologist) 2016 – Present — Liv Hospital Ulus, Department of Medical Oncology

Clinical Research and Phase III Trial Participation

• Phase III study of Ixabepilone (BMS-247550, an epothilone B analogue) in combination with capecitabine in patients with advanced breast cancer previously treated with an anthracycline or taxane (Protocol No: CA163-048; Coordinating Centre: Hacettepe University Faculty of Medicine; Principal Investigator: Prof. Dr. Esmen Baltacı; Co-investigator)
• Phase III randomised, placebo-controlled, double-blind study comparing oral CCI-779 (Temsirolimus) in combination with letrozole versus letrozole alone in first-line hormone therapy in postmenopausal women with locally advanced or metastatic breast carcinoma (Protocol No: 3066A1-303-WW; Coordinating Centre: Istanbul University Oncology Institute; Principal Investigator: Prof. Dr. Pınar Saip; Co-investigator)

Courses Attended

A detailed list of attended courses and workshops could not be located in publicly available sources. Obtaining the doctor's official CV is recommended to complete this section.

Scientific Awards

Second Prize, Oncology Research — XVII. National Cancer Congress, Turkish Association for Cancer Research and Control Soydinç H, Çamlıca H, Duranyıldız D, Güney N, Derin D, Taş F, Dalay N, Yasasever V. "The Utility of the Serum and Urine uPAR Levels in Breast Cancer."

Certifications

A detailed list of formal certifications and board diplomas could not be located in publicly available sources. Obtaining the doctor's official CV is recommended to complete this section.

Selected International Peer-Reviewed Articles

Soydinç HO, Duranyıldız D, Güney N, Derin D, Yasasever V. Utility of serum and urine uPAR levels for diagnosis of breast cancer. Asian Pacific Journal of Cancer Prevention, 2012;13(6):2887–2889.

Vural B, Yakar F, Derin D, Saip P, Yakar A, Demirkan A, Karabulut A, Ugurel E, Cine N, Kılıçaslan Z, Tüzün E, Özbek U. Evaluation of glutathione S-transferase P1 polymorphisms (Ile105Val and Ala114Val) in patients with small-cell lung cancer. Genetic Testing and Molecular Biomarkers, 2012;16(7):701–706.

Saip P, Şen F, Vural B, Ugurel E, Demirkan A, Derin D, Eralp Y, Çamlıca H, Üstüner Z, Özbek U. Glutathione S-transferase P1 polymorphisms are associated with time to tumour progression in small-cell lung cancer patients. Journal of B.U.ON., 2011;16(2):241–246.

Özlük Y, Kılıçaslan İ, Kazancıoğlu R, Demirkesen C, Derin D, Mandel NM. Intraglomerular crescentic metastases of malignant melanoma. Human Pathology, 2011;42(12):2025–2028.

Beyazıt H, Aydın O, Demirkesen C, Derin D, Süt P, Emre A, Mandel N. Pancreatic panniculitis as the first sign of pancreatic involvement during the course of gastric adenocarcinoma. Medical Oncology, 2011;28(1):137–139.

Bitisik O, Saip P, Sağlam S, Derin D, Dalay N. Mammaglobin and maspin transcripts in blood may reflect disease progression and treatment effect in breast cancer. Genetics and Molecular Research, 2010;9(1):97–106.

Başaran G, Okkan S, Çağlar H, Benekli M, Gümüş M, Haydaroğlu A, Eralp Y, Abalı H, Yıldız F, Bese N, Gursel B, Güney N, Derin D. Immunohistochemically defined T1N0 breast cancer subgroups have different clinical outcomes: a retrospective Turkish Oncology Group study. Cancer Research, 2010;69(24 Suppl): SABCS-09-3167.

Can G, Topuz E, Derin D, Durna Z, Aydıner A. The effect of kefir on quality of life in colorectal cancer patients. Oncology Nursing Forum, 2009;36(6):E335–E342.

Guney N, Soydinç HO, Başaran M, Bavbek S, Derin D, Çamlıca H, Yasasever V, Topuz E. Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma. Asian Pacific Journal of Cancer Prevention, 2009;10(4):669–674.

Guney N, Sayılgan T, Derin D, Özcan D. Primary carcinoid tumour arising in mature cystic teratoma of the ovary: a case report. European Journal of Gynaecological Oncology, 2009;30(2):223–225.

The full list of publications is available through the official Liv Hospital profile page and PubMed.